✨ Miscellaneous Notices
NEW ZEALAND GAZETTE, No. 126 — 19 NOVEMBER 2015
ongoing compliance as though it were a debt issuer in the ordinary course of business would be
disproportionate to the benefits.
c. The conditions ensure:
i. It continues to be appropriate to treat the company as an administrative funding vehicle for the
Spark Group in that it must continue to be wholly owned by the Spark Group and 95% of
subscriptions raised are for on-lending to the Spark Group; and
ii. The risk profile of the company remains consistent with that of an occasional or one-off issuer in
that the issue of debt securities, whether from within the company or from other parts of the Spark
Group, is not a financial activity carried on in the ordinary course of business of the Spark Group
taken as a whole.
-
This exemption comes into force on the day after the date I grant this exemption (9 November 2015).
-
This exemption will expire on 30 June 2018.
Any person wishing to provide comment on this notice should contact the Criminal Law Team at the Ministry of
Justice by emailing international.crime@justice.govt.nz
2015-go6756
Notice Under Clause 11 of Schedule 5 of the Overseas Investment Regulations 2005
For the period 1 January 2016 to the close of 31 December 2016, the threshold for Australian non-government
investments is $498 million, and the threshold for Australian government investments is $104 million.
Dated this 15th day of November 2015.
ANNELIES McCLURE, Manager, Overseas Investment Office.
2015-go6757
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in
New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Dysport
Active Ingredient: Clostridium botulinum type A toxin haemagglutinin complex 300U
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Ipsen Biopharm Limited, Wrexham, United Kingdom
Dated this 13th day of November 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister
of Health on 11 September 2013).
2015-go6775
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in
New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section
24(5) of the Act and are set out in the Schedule hereto:
Schedule
108
Next Page →
✨ LLM interpretation of page content
⚖️
Ministerial Exemptions Under the Anti-Money Laundering and Countering Financing of Terrorism Act 2009
(continued from previous page)
⚖️ Justice & Law EnforcementExemptions, Anti-Money Laundering, Countering Financing of Terrorism, Spark Finance Limited
🏭 Notice Under Clause 11 of Schedule 5 of the Overseas Investment Regulations 2005
🏭 Trade, Customs & Industry15 November 2015
Investment thresholds, Australian investments, Overseas Investment Regulations
- ANNELIES McCLURE, Manager, Overseas Investment Office
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare13 November 2015
Medicines, Distribution consent, Dysport, Clostridium botulinum toxin
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare13 November 2015
Medicines, Distribution consent, Medicines Act 1981
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 126